Since New Jersey’s first heart transplant was performed at Newark
Beth Israel in 1986 the Heart Failure Treatment
and Transplant Program has evolved into one of
the nation’s most
active and respected centers. The experienced multidisciplinary
team has worked together under the leadership of Mark J. Zucker, MD,
JD, for nearly 20 years and performed more than 530 heart transplants.
A comprehensive approach to care, special attention to every detail
and ongoing support for recipients and families distinguish the program.
Newark Beth Israel has achieved long- and short-term graft survival
rates that consistently exceed national averages
and ranks among the nations’ top programs by volume. Aggressive
in the treatment of end-stage organ disease and known across the country
as strong advocates for transplant candidates, the Heart Failure Treatment
and Transplant Program offers treatment not available elsewhere. The
team’s experience
has made it a principal site for numerous clinical
research trials that offer people diagnosed with heart failure or end-stage
heart disease the benefit of cutting-edge therapies. Newark Beth
Israel was the first to introduce the use of implantable ventricular
assist devices VADS in New Jersey in 1993 and remains one of the East
Coast’s
principal centers for implantation of the latest
generation of mechanical assist devices that replace a diseased heart’s
pumping action while the patient waits for a compatible organ. These
devices are also available for long-term treatment of heart failure
in patients who are not candidates for transplant.
For more information about the Heart Transplant Program, call
973-926-7205 or visit www.barnabashealth.org/heartcenters and
click on Heart and Lung Transplant.
Date: March 23, 2010
Contact: Caren Malone
Public Relations Department
Saint Barnabas Health
Care System
973-322-4017, cmalone@barnabashealth.org
[ top ] [ back to News Index ]
|
